Cleared Special

HemosIL D-Dimer HS

K160885 · Instrumentation Laboratory CO · Hematology
Oct 2016
Decision
210d
Days
Class 2
Risk

About This 510(k) Submission

K160885 is an FDA 510(k) clearance for the HemosIL D-Dimer HS, a Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control (Class II — Special Controls, product code DAP), submitted by Instrumentation Laboratory CO (Bedford, US). The FDA issued a Cleared decision on October 27, 2016, 210 days after receiving the submission on March 31, 2016. This device falls under the Hematology review panel. Regulated under 21 CFR 864.7320.

Submission Details

510(k) Number K160885 FDA.gov
FDA Decision Cleared SESE
Date Received March 31, 2016
Decision Date October 27, 2016
Days to Decision 210 days
Submission Type Special
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code DAP — Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control
Device Class Class II — Special Controls
CFR Regulation 21 CFR 864.7320

Similar Devices — DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control

All 56
HemosIL D-Dimer HS 500
K172903 · Instrumentation Laboratory CO · Nov 2017
STA? - Liatest? D-Di
K162227 · Diagnostica-Stago · Dec 2016
HemosIL D-Dimer HS
K151534 · Instrumentation Laboratory CO · Jul 2015
STA LIATEST D-DI
K141144 · Diagnostica-Stago · Sep 2014
VIDAS D-DIMER EXCLUSION II (DEX2)
K112818 · bioMerieux, Inc. · Jul 2012
STRATUS CS ACUTE CARE D-DIMER
K110303 · Siemens Healthcare Diagnostics · May 2011